Description
The Tumor Markers Test Kit YGA1339 // YGA1356 is an advanced diagnostic solution tailored for the early detection and monitoring of cancer through precise tumor marker analysis. Compatible with various Chemiluminescence Immunoassay Analyzers such as the YR06389 and YR06390, this kit provides a comprehensive array of tests for markers like AFP, CEA, CA125, and CA15-3, among others. These capabilities ensure healthcare professionals can effectively diagnose and track cancers including prostate, ovarian, and liver. Enhanced by the accuracy of CLIA technology, the kit is essential for precise cancer management and treatment strategies.
Market Price
The Tumor Markers Test Kit YGA1339 // YGA1356 is offered at a competitive price range from $2.50 to $5.00 per test, depending on order volume and specific configurations. This pricing flexibility benefits laboratories and healthcare providers looking for cost-effective diagnostic solutions tailored to their testing needs.
Frequently Asked Questions
What tumor markers does the Tumor Markers Test Kit test for? The kit tests for numerous tumor markers including AFP, CEA, CA125, CA15-3, and others essential for effective cancer diagnosis and monitoring.
What analysis method does the kit use? It utilizes Chemiluminescence Immunoassay (CLIA), known for its high precision and reliability in detecting tumor markers.
Can the kit be used with all Chemiluminescence Immunoassay Analyzers? Yes, it is compatible with a wide range of CLIA-based analyzers, offering significant flexibility in laboratory settings.
Advantages and Disadvantages
Advantages:
- Comprehensive coverage of diverse tumor markers, aiding in the detection and monitoring of various cancer types.
- High accuracy and sensitivity thanks to the Chemiluminescence Immunoassay (CLIA) technology.
- Compatible with various CLIA platforms, ensuring seamless laboratory integration.
- Supports early diagnosis and effective cancer management, leading to improved patient outcomes.
Disadvantages:
- Requires storage between 2-8°C, which may pose challenges for portability and transport.
- May not be cost-effective for smaller healthcare facilities with limited testing requirements.
Product Use in the Field
The Tumor Markers Test Kit YGA1339 // YGA1356 is widely used in clinical laboratories, oncology centers, and hospitals for effective cancer detection and surveillance. Healthcare specialists rely on this kit to identify early cancer stages and to monitor disease progression and treatment effectiveness, ensuring timely and informed decisions in patient care. Its automation-friendly design enhances laboratory efficiency.
Recommendations
- Store the kit at temperatures between 2-8°C to maintain reagent potency and ensure reliable test outcomes.
- Regularly calibrate your Chemiluminescence Immunoassay Analyzer to maintain consistent test accuracy.
- Incorporate the kit into automated lab systems to reduce errors and enhance operational efficiency.
Technical Specifications
| Model | YGA1339 | YGA1340 | YGA1341 | YGA1342 | YGA1343 | YGA1344 | YGA1345 | YGA1346 | YGA1347 |
| Tested Parameter | AFP | CEA | FER | CA125 | CA15-3 | CA19-9 | t-PSA | f-PSA | SCC |
| Analysis Mode | CLIA | ||||||||
| Package Specification | 50T/BOX, 100T/BOX,24T/BOX | ||||||||
| Platform | AP(Alkaline Phosphatase) | ||||||||
| Storage | 2-8°C | ||||||||
| Calibration | 2/6 Points | ||||||||
| Certification | CE, ISO13485,FSC | ||||||||
| Model | YGA1348 | YGA1349 | YGA1350 | YGA1351 | YGA1352 | YGA1353 | YGA1354 | YGA1355 | YGA1356 |
| Tested Parameter | NSE | CA50 | PGI | PGII | CYFRA 21-1 | CA72-4 | CA242 | pro-GRP | HE4 |
| Analysis Mode | CLIA | ||||||||
| Package Specification | 50T/BOX, 100T/BOX,24T/BOX | ||||||||
| Platform | AP(Alkaline Phosphatase) | ||||||||
| Storage | 2-8°C | ||||||||
| Calibration | 2/6 Points | ||||||||
| Certification | CE, ISO13485,FSC | ||||||||



